TABLE 2

Secondary Outcomes

Mild Versus No PIVHSevere Versus No PIVHSevere Versus Mild PIVH
UaOR, CI or (n)aOR, CI or (n)UaOR, CI or (n)aOR, CI or (n)UaOR, CI or (n)aOR, CI or (n)
Death1.50,a 1.13–2.00N/A6.02,a 5.34–6.79N/A8.81,a 6.32–12.27N/A
No. studies (subject n)1 (2110)N/A2 (7355)N/A1 (819)N/A
CP1.47,a 1.16–1.871.00, 0.61–1.645.64,a 4.91–6.463.43,a 2.24–5.254.06,a 2.92–5.633.44,a 1.96–6.04
No studies (subject n)4 (4898)1 (1291)4 (9989)1 (1202)3 (1340)1 (451)
Cognitive delay1.95,a 1.50–2.531.41, 0.97–2.062.76,a 2.42–3.161.37, 0.79–2.382.40,a 1.50–3.841.46, 0.74–2.88
No. studies (subject n)4 (3266)2 (1653)3 (7922)1 (1202)2 (828)1 (451)
  • aOR, adjusted OR; N/A, not applicable; UaOR, unadjusted OR.

  • a OR with statistical significance (95% CI does not cross 1).